[Federal Register Volume 89, Number 120 (Friday, June 21, 2024)]
[Notices]
[Pages 52093-52094]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-13623]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Customer Experience Hub

    Notice is hereby given that, on April 17, 2024, pursuant to section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), The Customer Experience Hub (``CX 
Hub'') has filed written notifications simultaneously with the Attorney 
General and the Federal Trade Commission disclosing changes in its 
membership. The notifications were filed for the purpose of extending 
the Act's provisions limiting the recovery of antitrust plaintiffs to 
actual damages under specified circumstances.
    Specifically, 3 Aware LLC, Indianapolis, IN; Adeco LLC, Houston, 
TX; AGAPE Strategic Solutions of Maryland LLC, Hyattsville, MD; 
Alliance NCTN Foundation, Chicago, IL; Allvivo Vascular, Inc., Lake 
Forest, CA; American Cancer Society Cancer Action Network, Washington, 
DC; American Cancer Society, Inc., Atlanta, GA; American College of 
Radiology, Reston, VA; American Military Families Action Network, 
Tacoma, WA; Apricity Health, Inc., Houston, TX; Artyc PBC, Fremont, CA; 
Asante Bio, Tampa, FL; Austin Healthcare Council, Austin, TX; Baylor 
Research Institute dba Baylor Scott & White Research Institute, Dallas, 
TX; Beth Israel Lahey Health, Cambridge, MA; Betty's Health Company LLC 
dba Betty's Co., San Antonio, TX; BioInnovation Labs dba BioLabs, 
Cambridge, MA; BioNorthTexas Foundation, Irving, TX; Boston University, 
Boston, MA; Breathe Chicago Center at University of Illinois Chicago, 
Chicago, IL; Capital Factory Properties LLC, Austin, TX; Care Access 
Research LLC, Boston, MA; Carson Leslie Foundation, Dallas, TX; 
CentanniPark LLC, Somerville, MA; Central Indiana Corporate 
Partnership, Indianapolis, IN; CFD Research Corp., Huntsville, AL; 
Charles River Analytics, Inc., Cambridge, MA; Chicago ARC, Glenview, 
IL; Children's Cancer Therapy Development Institute, Hillsboro, OR; 
Clarivate Analytics (US) LLC, Ann Arbor, MI; Clinical Research 
Philadelphia LLC, Philadelphia, PA; Clinical Trials Transformation 
Initiative, Durham, NC; CliniOps, Inc., Fremont, CA; Cogitativo, Inc., 
Berkeley, CA; Critical Path Institute, Tucson, AZ; Cromtec Cyber 
Solutions, Inc., Houston, TX; Cx Precision Medicine, Fort Worth, TX; 
Dallas-Fort Worth Hospital Council, Irving, TX; Datavant, Inc., 
Phoenix, AZ; Decentralized Trials & Research Alliance (DTRA), San 
Diego, CA; DHR Health Institute for Research & Development, Edinburg, 
TX; Digital Medicine Society, Inc., Boston, MA; Driscoll Children's 
Hospital, Corpus Christi, TX; Duke University, Durham, NC; Endpoint 
Health, Palo Alto, CA; Environmental Information Systems Corp., Las 
Vegas, NV; Every Cure, Philadelphia, PA; Evidation Health, San Mateo, 
CA; Exo Imagining, Inc., Santa Clara, CA; Florida Institute of 
Technology, Inc., Melbourne, FL; Freyya, Inc., San Antonio, TX; Genetic 
Alliance, Inc., Damascus, MD; Global Coalition for Adaptive Research, 
Inc., Larkspur, CA; Guava Health, Inc., Santa Barbara, CA; Gulf South 
Clinical Trials Network, New Orleans, LA; Halo Health Systems, Plano, 
TX; Hamilton Health Box, Inc., Houston, TX; Harvard T.H. Chan School of 
Public Health, Boston, MA; Health Level Seven International, Inc., Ann 
Arbor, MI; Health Tech Austin, Austin, TX; Health Wildcatters, Dallas, 
TX; Healthcare Innovators Professional Society, Houston, TX; Hero 
Medical Technologies, Inc., Ponte Vedra Beach, FL; Hope Biosciences 
LLC, Sugar Land, TX; Huck Medical Technologies, Inc., Jacksonville, FL; 
Indiana University, Bloomington, IN; Insilicom LLC, Tallahassee, FL; 
Institute for Systems Biology, Seattle, WA; Iowa State University of 
Science and Technology, Ames, IA; IQVIA Government Solutions, Inc., 
Falls Church, VA; iTrials, Ashburn, VA; JAKTOOL LLC, Cranbury, NJ; 
LaunchBio, Inc., San Diego, CA; Levels Health, Austin, TX; Lone Star 
Stroke Research Consortium, San Antonio, TX; Mary Crowley Cancer 
Research, Dallas, TX; Massachusetts Health & Hospital Association, 
Burlington, MA; MATRIX AI Consortium, San Antonio, TX; Mayo Clinic, 
Rochester, MN; Meadows Mental Health Policy Institute, Dallas, TX; 
Mercury Data Science, Inc. dba OmniScience, Houston, TX; Milken 
Institute, Washington, DC; Modern Trials, Inc., Haddon Township, NJ; 
Momentum Design Lab LLC, San Mateo, CA; MPR Associates, Inc., 
Alexandria, VA; Music Beats Cancer, Washington, DC; MyEyes LLC, Heber, 
UT; NanOlogy LLC, Fort Worth, TX; Neelyx Labs, Inc., Wood Dale, IL; 
Panthera BioSolutions, Fort Worth, TX; Persown, Inc., Jacksonville, FL; 
Phage Refinery LLC, San Antonio, TX; Polaris Alpha Advanced Systems, 
Inc., Fredericksburg, VA; Precise Populations, Austin, TX; Providence 
Health & Services, Renton, VA; Quality by Randomization Ltd. dba 
Protas, Salford, UNITED KINGDOM; Quantum Leap Healthcare Collaborative, 
San Francisco, CA; Quidel Corp. dba QuidelOrtho, San Diego, CA; 
Radiological Society of North America, Inc., Oak Brook, IL; Retina 
Foundation, Dallas, TX; Rhode Island Health Center Association, 
Providence, RI; Rock Health Foundation, San Francisco, CA; Ruth Health, 
Bronx, NY; Safe Health Systems, Inc., Scottsdale, AZ; San Diego State 
University Foundation, San Diego, CA; Segal Design Institute at 
Northwestern University, Evanston, IL; Seven Bridges Genomics, Inc., 
Boston, MA; SiteBridge Research, Inc., Chapel Hill, NC; Southern 
Research Institute, Birmingham, AL; Spark Biomedical, Inc., Dallas, TX; 
SRI International, Menlo Park, CA; St. Mary's University of San 
Antonio, Texas, San Antonio, TX; SygnaMap, Inc., San Antonio, TX; 
Systems & Technology Research LLC, Woburn, MA; Texas A&M University 
System Health Science Center, Bryan, TX; The Children's Hospital of 
Philadelphia, Philadelphia, PA; The Medical College of Wisconsin, Inc., 
Milwaukee, WI; The Medical University of South Carolina, Charleston, 
SC; The Methodist Hospital Research Institute,

[[Page 52094]]

Houston, TX; The Regents of the University of California, San 
Francisco, San Francisco, CA; The University of Kansas Medical Center 
Research Institute, Inc., Kansas City, KS; The University of Texas at 
Arlington, Arlington, TX; The University of Texas Health Science Center 
at San Antonio, San Antonio, TX; Tonix Pharmaceuticals, Chatham, NJ; 
TQIntelligence, Inc., Tucker, GA; Tremedics Medical Devices LLC, Fort 
Worth, TX; Trustees of the University of Pennsylvania dba Clinical 
Practices of the University of Pennsylvania, Philadelphia, PA; UC 
Berkeley Haas Institute for Business Innovation, Berkeley, CA; UCSF: 
Eureka Research Platform, San Francisco, CA; University of Alabama at 
Birmingham, Birmingham, AL; University of Chicago, Chicago, IL; 
University of Colorado Anschutz Medical Campus, Aurora, CO; University 
of Iowa, Iowa City, IA; University of Massachusetts Medical School, 
Worcester, MA; University of the Virgin Islands, St. Thomas, VI; 
University of Utah, Salt Lake City, UT; Vanderbilt University Medical 
Center, Nashville, TN; Women's Health Access Matters, Greenwich, CT; 
Yunu, Inc., Cary, NC; and ZS Associates, Inc., Evanston, IL, have been 
added as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and the CX Hub intends to file 
additional written notifications disclosing all changes in membership.
    On January 11, 2024, the CX Hub filed its original notification 
pursuant to section 6(a) of the Act. The Department of Justice 
published a notice in the Federal Register pursuant to section 6(b) of 
the Act on April 16, 2024 (89 FR 26929).

Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-13623 Filed 6-20-24; 8:45 am]
BILLING CODE P